High regulatability favors genetic selection in SLC18A2, a vesicular monoamine transporter essential for life

被引:16
|
作者
Lin, Zhicheng [1 ,3 ]
Zhao, Ying [1 ,3 ]
Chung, Chee Yeun [2 ,4 ]
Zhou, Yanhong [1 ,3 ]
Xiong, Nian [1 ,3 ]
Glatt, Charles E. [5 ]
Isacson, Ole [2 ,4 ]
机构
[1] McLean Hosp, Div Alcohol & Drug Abuse, Belmont, MA 02478 USA
[2] McLean Hosp, Ctr Neuroregenerat Res, Belmont, MA 02478 USA
[3] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA
[5] Cornell Univ, Dept Psychiat, Weill Med Coll, New York, NY 10021 USA
来源
FASEB JOURNAL | 2010年 / 24卷 / 07期
基金
美国国家卫生研究院;
关键词
human; promoter haplotypes; evolution; signaling cascades; transcription; DOPAMINE TRANSPORTER; TRANSCRIPTION FACTOR; IN-VIVO; EXPRESSION; PROMOTER; PATHWAY; VMAT2; RAT; SCHIZOPHRENIA; HAPLOTYPES;
D O I
10.1096/fj.09-140368
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
SLC18A2 encodes the vesicular monoamine transporter 2 protein that regulates neurotransmission and reduces cytosolic toxicity of monoamines. Deletion of this gene causes lethality in mice, and DNA sequence variation in this gene is associated with alcoholism and Parkinson's disease, among other disorders. The Caucasian SLC18A2 promoter has at least 20 haplotypes (A-T), with A representing two-thirds of 1460 chromosomes. It is not known why A is selected in the human lineage. To understand the selection, here we took a functional approach by investigating the regulations of 4 representative haplotypes (A, C, G, and T) by 17 agents. We show that 76.5% of the agents were able to regulate A but only 11.8-23.5% of them regulated the 3 other infrequent ones, observing a positive correlation between haplotype frequency and regulatability. Pathway and molecular analyses revealed five signaling hubs that regulate the four haplotypes differentially, probably through targeting the polymorphic core promoter region. These findings suggest that greater diversity of transcriptional regulations is the driving force for the haplotype selection in SLC18A2.-Lin, Z., Zhao, Y., Chung, C. Y., Zhou, Y., Xiong, N., Glatt, C. E., Isacson, O. High regulatability favors genetic selection in SLC18A2, a vesicular monoamine transporter essential for life. FASEB J. 24, 2191-2200 (2010). www.fasebj.org
引用
收藏
页码:2191 / 2200
页数:10
相关论文
共 50 条
  • [1] Vesicular monoamine transporter 2 (SLC18A2) regulates monoamine turnover and brain development in zebrafish
    Baronio, Diego
    Chen, Yu-Chia
    Decker, Amanda R.
    Enckell, Louise
    Fernandez-Lopez, Blanca
    Semenova, Svetlana
    Puttonen, Henri A. J.
    Cornell, Robert A.
    Panula, Pertti
    ACTA PHYSIOLOGICA, 2022, 234 (01)
  • [2] Association study of the vesicular monoamine transporter gene SLC18A2 with tardive dyskinesia
    Zai, Clement C.
    Tiwari, Arun K.
    Mazzoco, Marina
    de Luca, Vincenzo
    Mueller, Daniel J.
    Shaikh, Sajid A.
    Lohoff, Falk W.
    Freeman, Natalie
    Voineskos, Aristotle N.
    Potkin, Steven G.
    Lieberman, Jeffrey A.
    Meltzer, Herbert Y.
    Remington, Gary
    Kennedy, James L.
    JOURNAL OF PSYCHIATRIC RESEARCH, 2013, 47 (11) : 1760 - 1765
  • [3] Increased Vesicular Monoamine Transporter 2 (VMAT2; Slc18a2) Protects against Methamphetamine Toxicity
    Lohr, Kelly M.
    Stout, Kristen A.
    Dunn, Amy R.
    Wang, Minzheng
    Salahpour, Ali
    Guillot, Thomas S.
    Miller, Gary W.
    ACS CHEMICAL NEUROSCIENCE, 2015, 6 (05): : 790 - 799
  • [4] Assignment of the mouse vesicular monoamine transporter genes, Slc18a1 and Slc18a2, to chromosomes 8 and 19 by linkage analysis
    Roghani, A
    Welch, C
    Xia, YR
    Liu, Y
    Peter, D
    Finn, JP
    Edwards, RH
    Lusis, AJ
    MAMMALIAN GENOME, 1996, 7 (05) : 393 - 394
  • [5] The Effects of Gene Knockout of the Vesicular Monoamine Transporter 2 (VMAT2; SLC18A2) and the Dopamine Transporter (DAT; SLC3A6) on Ethanol Consumption and Escalation in Mice
    Hall, Frank S.
    Houston-Ludlam, Alexandra
    Lin, Zhicheng
    Uhl, George
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S565 - S565
  • [6] Association of DNA Polymorphisms in the Synaptic Vesicular Amine Transporter Gene (SLC18A2) with Alcohol and Nicotine Dependence
    Sibylle G Schwab
    Petra E Franke
    Barbara Hoefgen
    Vera Guttenthaler
    Dirk Lichtermann
    Matyas Trixler
    Michael Knapp
    Wolfgang Maier
    Dieter B Wildenauer
    Neuropsychopharmacology, 2005, 30 : 2263 - 2268
  • [7] Brain monoamine vesicular transport disease caused by homozygous SLC18A2 variants: A study in 42 affected individuals
    Saida, Ken
    Marootain, Reza
    Sengoku, Toru
    Mitani, Tadahiro
    Pagnamenta, Alistair T.
    Marafi, Dana
    Zaki, Maha S.
    O'Brian, Thomas J.
    Karimiani, Ehsan Ghayoor
    Kaiyrzhanov, Rauan
    Takizawa, Marina
    Ohori, Sachiko
    Leong, Huey Yin
    Akay, Gulsen
    Galehdari, Hamid
    Zamani, Mina
    Romy, Ratna
    Carroll, Christopher J.
    Toosi, Mehran Beiraghi
    Ashrafzadeh, Farah
    Imannezhad, Shima
    Malek, Hadis
    Ahangari, Najmeh
    Tomoum, Hoda
    Gowda, Vykuntaraju K.
    Srinivasan, Varunvenkat M.
    Murphy, David
    Dominik, Natalia
    Elbendary, Hasnaa M.
    Rafat, Karima
    Yilmaz, Sanem
    Kanmaz, Seda
    Serin, Mine
    Krishnakumar, Deepa
    Gardham, Alice
    Maw, Anna
    Rao, Tekki Sreenivasa
    Alsubhi, Sarah
    Srour, Myriam
    Buhas, Daniela
    Jewett, Tamison
    Goldberg, Rachel E.
    Shamseldin, Hanan
    Frengen, Eirik
    Misceo, Doriana
    Stromme, Petter
    Ceroni, Jose Ricardo Magliocco
    Kim, Chong Ae
    Yesil, Gozde
    Sengenc, Esma
    GENETICS IN MEDICINE, 2023, 25 (01) : 90 - 102
  • [8] Association of DNA polymorphisms in the synaptic vesicular amine transporter gene (SLC18A2) with alcohol- and nicotine dependence
    Wildenauer, DB
    Knapp, M
    Franke, P
    Hoefgen, B
    Trixler, M
    Maier, W
    Schwab, SG
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2005, 138B (01) : 17 - 17
  • [9] Genetic Variation in the Vesicular Monoamine Transporter 1 (VMAT1/SLC18A1) Gene and Alcohol Withdrawal Severity
    Dutta, Nisha
    Helton, Sarah G.
    Schwandt, Melanie
    Zhu, Xi
    Momenan, Reza
    Lohoff, Falk W.
    ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 2016, 40 (03): : 474 - 481
  • [10] Decreased limbic vesicular monoamine transporter 2 in a genetic rat model of depression
    Schwartz, K
    Yadid, G
    Weizmann, A
    Rehavi, M
    BRAIN RESEARCH, 2003, 965 (1-2) : 174 - 179